##  [Drug Importation to India A Regulatory Blueprint](/index%2Ephp/webinars/drug-importation-to-india-a-regulatory-blueprint) 

<a>Medical Devices</a>



<a>Past Webinar</a>



## **Designing Operation Manuals for Medical Devices**

**The webinar was successfully concluded on**

  **June 17, 2021.**

[Download Webinar](javascript:void(0))





Thank you for your interest in Freyr’s Webinar Series (FWS). The webinar on, “**Drug Importation to India- A Regulatory Blueprint,”** was successfully concluded on June 17, 2021. Here is an archived version for your perusal.

#### What Was It All About?

In this webinar, our Indian Regulatory experts - Dr Ghulam Moinuddin and Michael Lambell have elaborated:

- Overview to Indian Pharma Market &amp; CDSCO/DCGI
- Why India? (potential of pharma business in Indian market)
- India on Priority: Top 5 Global Pharmaceuticals/Bio-Pharmaceutical MNCs
- India-Regulatory pathway: Marketing Authorization Approval/Import Permission; Registration of Manufacturing Facility; Import License
- Clinical Trial Approval
- Rationale for New Drug Approval and Requirements
- Authorized Indian Agent and Warehouse: Overview
- Regulatory Challenges Faced by a New Applicant
- Success Story

As a continuous practice, Freyr is destined to organize more webinar sessions related to Regulatory aspects of Life Sciences. We presume that you would like to be a part of all those sessions. If yes, let us have an opportunity to inform you about our next session.